AV8 Ventures is an Allianz-backed early-stage venture capital firm that focuses on Seed and Series A investments in healthcare, enterprise software, financial services/insurtech, and deep technology. The firm's strategy involves partnering with visionary founders to build category-defining companies, offering both capital and strategic support to help them achieve product-market fit and scale.
Portfolio
9
Fund Size
$360M
Top Stage
Seed
Last 12 Mo
2
Stage Distribution
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Think Bioscience | Series A | $55M | Jan 2026 |
| Hydrolix | Series C | $80M | Apr 2025 |
| Glow | Series A | $22.5M | Nov 2022 |
| CoverTree | Seed | $10M | Sep 2022 |
| Think Bioscience | Seed | $17M | Aug 2022 |
| WAX Insurance Services | Seed | $10M | May 2022 |
| Alpha Medical | Series B | $24M | Sep 2021 |
| Hydrolix | Seed | $10M | Feb 2021 |
| DELFI Diagnostics, Inc. | Series A | $100M | Jan 2021 |
Top Co-Investors
Wing2 shared
Innovation Endeavors2 shared
Buff Gold Ventures2 shared
QED Investors1 shared
Sozo Ventures1 shared
Frontline Ventures1 shared
Blumberg Capital1 shared
Uncorrelated Ventures1 shared
Oregon Venture Fund1 shared
Silicon Valley Data Capital1 shared
Samsung Next1 shared
GSR Ventures1 shared
Slow Ventures1 shared
Janus Henderson Investors1 shared
MBX Capital1 shared
YK Bioventures1 shared
Distributed Ventures1 shared
Detroit Venture Partners1 shared
OrbiMed1 shared
Menlo Ventures1 shared
Last updated: 3 March 2026